CELLULAR STRESS RESPONSES, THE HORMESIS PARADIGM AND VITAGENES: NOVEL TARGETS FOR THERAPEUTIC INTERVENTION IN NEURODEGENERATIVE DISORDERS

http://www.liebertonline.com/doi/abs/10.1089/ars.2009.3074?mi=3b5d62&af=R&BeforeMonth=null&journalCode=null&issue=null&nh=20&AfterMonth=null&prevSearch=allfield%253A%2528%2522Friedreich%2527s%2522%2Bor%2B%2522Friedreich%2522%2Bor%2B%2522FRDA%2522%2529&discipline=null&group=null&restrict=all&result=true&filter=multiple&year=null&startPage=0&journal=null&AfterYear=null&favoriteJIds=null&sortBy=date&BeforeYear=null&doi=null&target=simple

Online Ahead of Editing: May 6, 2010

Antioxidants & Redox Signaling. null, Vol. 0, No. ja

doi:10.1089/ars.2009.3074.  

Prof. Vittorio Calabrese,University of Catania, Department of Chemistry, Catania, Italy; Dr. Carolin Cornelius,University of Catania, Department of Chemistry, Catania, Italy; Prof. Albena T. Dinkova-Kostova,University of Dundee, The Biomedical Research Institute, Dundee, United Kingdom; Prof. Edward J. Calabrese

University of Massachusetts, Environmental Health Sciences Division, School of Public Health, Amherst, Massachusetts, United States; Dr. Mark Mattson, National Institute on Aging, Intramural Research Program, Baltimore, Maryland, United States;

Keywords:  chronic oxidative stress,  metabolic and neurodegenerative diseases,  hormesis,  neuroprotection, biological plasticity, therapeutic dose, pharmaceutical agents, sirtuin, Nrfs,  nitric oxide, carbon monoxide, H2S, mitochondrial redox signaling.